Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. As of November 28, a total of 23 cases have been identified; 11 were confirmed as inhalational anthrax, and 12 (seven confirmed and five suspected) were cutaneous. Epidemiologic investigations to identify the source of exposure to Bacillus anthracis continue for a case of inhalational anthrax in a hospital stockroom worker in New York City (NYC) and, most recently, a case of inhalational anthrax in an elderly woman in Connecticut (CT). Antimicrobial prophylaxis is continuing in persons exposed to B. anthracis, and surveillance to detect new cases of bioterrorism-related anthrax is ongoing. This report summarizes the findings of the case investigation in CT.
D000368:Aged; D000369:Aged, 80 and over; D000881:Anthrax / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001408:Bacillus anthracis / Q000302:isolation & purification*; D023482:Bioterrorism; D003237:Connecticut / Q000453:epidemiology; D004781:Environmental Exposure; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D011177:Postal Service; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D017192:Skin Diseases, Bacterial / Q000453:epidemiology*; D013171:Spores, Bacterial / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents